Catherine Delbaldo

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy, Françoise Desseigne, Marc Ychou et al. · New England Journal of Medicine · 2011 · 7.8K citations · Full text

Medicine, Oncology, Pharmacology +13

Safety, Pharmacokinetic, and Antitumor Activity of SU11248, a Novel Oral Multitarget Tyrosine Kinase Inhibitor, in Patients With Cancer

Sandrine Faivre, Catherine Delbaldo, Karina Vera et al. · Journal of Clinical Oncology · 2005 · 1.2K citations · Full text

Pharmacy, Oncology, Pharmacology +17

Prospective Multicentric Randomized Phase III Study of Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors Comparing Interruption Versus Continuation of Treatment Beyond 1 Year: The French Sarcoma Group

Jean‐Yves Blay, Axel Le Cesne, Isabelle Ray‐Coquard et al. · Journal of Clinical Oncology · 2007 · 391 citations

Medicine, Oncology, Pharmacotherapy +11

Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies

Christophe Le Tourneau, Sandrine Faivre, Valérie Laurence et al. · European Journal of Cancer · 2010 · 167 citations

Medicine, Oncology, Pharmacology +12

Population Pharmacokinetics and Pharmacogenetics of Imatinib in Children and Adults

Aurélie Pétain, Darouna Kattygnarath, Julie Azard et al. · Clinical Cancer Research · 2008 · 163 citations

Pharmacy, Pharmacokinetics, Pharmacology +17